Matica Biotechnology and Cha Biotech: Leading the Future of Cell and Gene Therapy
The biotech industry has seen rapid growth in recent years, with the cell and gene therapy (CGT) market drawing significant attention. Paul Kim, CEO of Matica Biotechnology, announced plans to build a second plant in Texas with a 2000-liter capacity to address the growing market demand. This announcement was made at the ‘2024 BIO International … 더 읽기